I had 11 years of chemotherapy for a cancer I didn't have

I had 11 years of chemotherapy for a cancer I didn't have

Becky Jones received a devastating diagnosis at just 21 years old, being told she had a terminal brain tumour and only months left to live. At that time, she was starting a new relationship and aspiring towards a career in policing, but the grim prognosis overshadowed her future. Under the care of an experienced cancer consultant, she endured 11 years of chemotherapy, a treatment course that brought constant nausea, fatigue, and prevented her from engaging fully in family life or pursuing her ambitions. Only recently, at age 33, was she informed that she never had cancer; instead, she had an inflammatory brain condition that could have been treated with steroids.

Jones is among more than 40 patients taking legal action against University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, alleging prolonged or unnecessary cancer treatments. According to Jones, the consultant, Professor Ian Brown, insisted she would need to remain on the chemotherapy drug temozolomide (TMZ) for life, despite medical guidelines recommending only six cycles over six months. When she noticed multiple scans failed to show any tumour evidence, she was told the tumour would not be “visible to the naked eye.” It was during a review of cancer cases involving Brown in 2025 that Jones discovered the truth: she had been misdiagnosed and treated for a cancer she never had. She expressed the impact of this revelation starkly, saying, “He’s just ruined my life, essentially.”

Multiple patients who were under Brown’s care have reported similar experiences of extended TMZ treatment, leading to serious health consequences. For example, one patient suspects the drug caused infertility, while another developed leukaemia after undergoing 100 unnecessary cycles. A preliminary review by the Royal College of Physicians found that patients at the hospital often received prolonged TMZ courses with little or no benefit, describing hospital staff failings as a “betrayal of patient trust.” The review also questioned why the oncology pharmacy teams did not intervene despite patients being treated with oral chemotherapy continuously for a decade or more. UHCW has declined to comment on individual cases but stated that steps have been taken to improve oversight on TMZ use.

Becky Jones recalled her chemotherapy years as “horrendous,” detailing relentless nausea, stomach pains, mouth ulcers, and daily fatigue. The treatment curtailed her previously active lifestyle, stopped social and family interactions due to infection fears, and even led to restrictions on her driving licence. Despite being told she would be unable to conceive, she later had two children, which doctors described as miracles. Her ordeal came to an abrupt halt in 2024 when a doctor informed her chemotherapy was ending because Professor Brown had retired, a fact she had not previously known. In May 2025, further independent medical assessments revealed that her original diagnosis was incorrect: she had tumefactive demyelination, an inflammatory brain condition typically treated with steroids, not chemotherapy. The emotional impact of this revelation was profound, eliciting tears among Jones and her legal team.

The Royal College of Physicians’ preliminary review, while not naming Professor Brown directly but referring to him as “Dr Y,” found that 15 out of 20 cases reviewed were “unsatisfactory overall.” It noted poor documentation and communication regarding the risks of TMZ, insufficient clinical curiosity, and a lack of collaborative decision-making that allowed misdiagnoses to persist unchecked. Jones described these findings as “chilling,” highlighting her feeling that Brown had operated unchecked, with little oversight from colleagues or hospital administration.

In response to these findings, UHCW has stated that all affected patients have been reviewed by senior clinicians and that appropriate care plans are now in place. The Trust also announced an independent review into their internal “speak-up” processes to ensure that staff feel supported and confident in raising concerns. They emphasized that patient safety, experience, and wellbeing are their highest priorities and pledged to take further action based on the Royal College of Physicians’ full review once it is published

Read the full article from The BBC here: Read More